Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Other Non-Current Assets (2023 - 2025)

Historic Other Non-Current Assets for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to $394000.0.

  • Mereo BioPharma's Other Non-Current Assets fell 983.98% to $394000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $394000.0, marking a year-over-year decrease of 983.98%. This contributed to the annual value of $378000.0 for FY2024, which is 3853.66% down from last year.
  • Per Mereo BioPharma's latest filing, its Other Non-Current Assets stood at $394000.0 for Q3 2025, which was down 983.98% from $402000.0 recorded in Q2 2025.
  • Mereo BioPharma's 5-year Other Non-Current Assets high stood at $615000.0 for Q4 2023, and its period low was $378000.0 during Q4 2024.
  • Its 3-year average for Other Non-Current Assets is $440142.9, with a median of $402000.0 in 2025.
  • In the last 5 years, Mereo BioPharma's Other Non-Current Assets tumbled by 3853.66% in 2024 and then crashed by 983.98% in 2025.
  • Quarter analysis of 3 years shows Mereo BioPharma's Other Non-Current Assets stood at $615000.0 in 2023, then plummeted by 38.54% to $378000.0 in 2024, then rose by 4.23% to $394000.0 in 2025.
  • Its last three reported values are $394000.0 in Q3 2025, $402000.0 for Q2 2025, and $380000.0 during Q1 2025.